Does Doximity Inc (NYSE:DOCS) Look Expensive At $30.25? Here’s How To Know.

In recent trading session, Doximity Inc (NYSE:DOCS) saw 3.67 million shares changing hands at last check today with its beta currently measuring 1.19. Company’s recent per share price level of $30.25 trading at $2.01 or 7.13% at last check today assigns it a market valuation of $5.62B. That most recent trading price of DOCS’s stock is at a discount of -25.95% from its 52-week high price of $38.10 and is indicating a premium of 34.84% from its 52-week low price of $19.71. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.81 million shares which gives us an average trading volume of 1.96 million if we extend that period to 3-months.

Doximity Inc (NYSE:DOCS) trade information

Upright in the green today for gaining 7.13%, in the last five days DOCS remained trading in the green while hitting it’s week-highest on Friday, 02/09/24 when the stock touched $30.25 price level, adding 1.05% to its value on the day. Doximity Inc’s shares saw a change of 7.90% in year-to-date performance and have moved 10.05% in past 5-day. Doximity Inc (NYSE:DOCS) showed a performance of 6.19% in past 30-days. Number of shares sold short was 8.7 million shares which calculate 4.68 days to cover the short interests.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Doximity Inc (DOCS) estimates and forecasts

Statistics highlight that Doximity Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 21.45% of value to its shares in past 6 months, showing an annual growth rate of 17.81% while that of industry is 4.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 11.70% from the last financial year’s standing.

14 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $117.86 million for the same. And 11 analysts are in estimates of company making revenue of $118.7 million in the next quarter that will end on Jun 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 255.76% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 20.76% while estimates for its earnings growth in next 5 years are of 8.80%.

DOCS Dividends

Doximity Inc is more likely to be releasing its next quarterly report on February 08 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Doximity Inc (NYSE:DOCS)’s Major holders

Insiders are in possession of 4.25% of company’s total shares while institution are holding 83.16 percent of that, with stock having share float percentage of 86.85%. Investors also watch the number of corporate investors in a company very closely, which is 83.16% institutions for Doximity Inc that are currently holding shares of the company. Morgan Stanley is the top institutional holder at DOCS for having 11.38 million shares of worth $387.16 million. And as of Jun 29, 2023, it was holding 9.07% of the company’s outstanding shares.

The second largest institutional holder is Blackrock Inc., which was holding about 10.69 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 8.52% of outstanding shares, having a total worth of $363.62 million.

On the other hand, iShares Core S&P Midcap ETF and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 29, 2023, the former fund manager was holding 3.93 million shares of worth $83.3 million or 3.13% of the total outstanding shares. The later fund manager was in possession of 3.34 million shares on Jun 29, 2023, making its stake of worth around $113.5 million in the company or a holder of 2.66% of company’s stock.

On Key

Related Posts